BioWorld MedTech

Aug. 27, 2018

Senate spending bill for NIH seeks money for drug pricing regulations

The U.S. Senate passed a spending bill that would provide the National Institutes of Health with roughly $39 billion in the coming fiscal year, but the legislation also provides funding for development of drug pricing regulations. Read More

Oxford Biodynamics secures Chinese marketing partner and $12.5M in funding

Researchers use advanced retinal imaging to identify presymptomatic AD patients

Intelligent products are becoming focus of China's future med-tech industry

Head lamp: Rakuten bid with light-activated drug draws $150M in series C

Product briefs

BioWorld MedTech stock report for public med-tech companies

Other news to note

Daily M&A

BioWorld MedTech's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan. 13, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for January 13, 2025

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

BioWorld

The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...

Proteomics study explores how protein changes influence disease

BioWorld Science

Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

BioWorld

Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...